2056-2057 / 2351
•
Median survival of patients is 6-8 months
•
No evidence that chemotherapy prolongs survival
•
Polychemotherapy versus monochemotherapy:
-
Higher response rate
-
More toxic
-
No improvement in survival
•
Cisplatin /5-FU
•
Cisplatin /paclitaxel
•
Methotrexate (40 mg/m2/every week)
Chemotherapy: conclusions